Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-17-005342

Options or other derivatives

  • President and CEO acquired 77,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chan Phillip P. President and CEO 2017-01-30 Grant or award · Stock Option (right to buy) +77,600 77,600 D
Loading xslF345X03/v458127_4.xml…